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Purpose: This study aimed to assess the extent of patient, health system and total delays in
diagnosis and treatment of pulmonary tuberculosis (TB) in Somali pastoralist setting,
Ethiopia.
Patients and Methods: A cross-sectional study among 444 confirmed new pulmonary TB
patients aged ≥15 years in 5 TB care units was conducted between December 2017 and
October 2018. Data were collected using a structured questionnaire and record review. We
measured delays from symptom onset to provider visit, provider visit to diagnosis and
diagnosis to treatment initiation. Delays were summarized using median days. Mann–
Whitney and Kruskal–Wallis tests were used to compare delays between categories of
explanatory variables. The Log-binomial regression model was used to reveal factors
associated with health system delay ≥15 days, presented in adjusted prevalence ratio
(APR) with 95% confidence interval (CI).
Results: The median age of patients was 30 years, ranged from 15 to 82. The majority
(62.4%) were male, and nearly half (46.4%) were pastoralists. The median patient, health
system and total delays were 30 (19–48.5), 14 (4.5–29.5) and 50 (35–73.5) days, respec-
tively. The median patient delay (35.5 days) and total delay (58.5 days) among pastoralists
were substantially higher than the equivalent delays among non-pastoralists [p<0.001]. Of
all, 3.8% of patients (16 of 18 were pastoralists) delayed longer than 6 months without
initiating treatment. Factors associated with health system delay ≥15 days were mild
symptoms [APR (95% CI) = 1.4 (1.1–1.7)], smear-negativity [APR (95% CI) = 1.2 (1.01–
1.5)], first visit to health centers [APR (95% CI) = 1.6 (1.3–2.0)] and multiple provider
contacts [APR (95% CI) = 5.8 (3.5–9.6)].
Conclusion: Delay in diagnosis and treatment remains a major challenge of tuberculosis
control targets in pastoralist settings of Ethiopia. Efforts to expand services tailored to
transhumance patterns and diagnostic capacity of primary healthcare units need to be
prioritized.
Keywords: patient delay, health system delay, total delay, tuberculosis, pastoralist
Introduction
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis. Globally, an
estimated 10 million people got ill with TB, and over 1.4 million died from the disease
in 2018. Ethiopia is one of the highly affected countries, ranking 9th among the high
burden countries, 3rd in Africa, and one of the few countries with triple TB, multi-drug
resistant TB (MDR-TB) and TB/HIV burden.1 The national TB survey indicated that
pastoral communities had the highest toll of TB prevalence in Ethiopia.2 The global
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End-TB Strategy relies on early diagnosis and treatment of
cases as a principal tool to improve patient outcomes, prevent
drug resistance, interrupt transmission, and ultimately to end
TB epidemics by 2030.3 The national TB control program
(NTP) of Ethiopia primarily strives to achieve this target
through effective detection of symptomatic TB cases who
present themselves to health facilities, also known as passive
case-finding strategy.4
This widely used passive approach in resource-limited
settings, however, flunks to bring the planned case detection
rates, as a result, millions of TB cases are missed from being
detected.5,6 In Ethiopia, over a third of the estimated 165,000
TB cases were not notified and treated in 2018.1 A large
number of cases are missed; community-based studies in the
country have indicated themagnitude of undetected TB cases
in communities could be equal or larger than notified
cases.6,7 Despite the drastic expansion of health services in
the Somali Regional State of Ethiopia, the case detection rate
remained the lowest at 34% in 2015 given the target was 70%
and has not surpassed 50% in subsequent years.8 The ineffec-
tiveness of this passive process in achieving the required case
detection rates could be due to the poor healthcare-seeking
practice of symptomatic patients, or could be due to the
health system capability to examine and detect presented
cases.9,10 This denotes medical help-seeking behavior of
patients, accessibility of quality diagnostic facilities, and
competence and efficiency of healthcare providers to suspect
and investigate presumptive TB cases are crucial to ensure
early diagnosis and treatment initiation.
However, patients’ delay in seeking medical help and
health system’s delay in detecting TB cases presented to
health facilities has remained problematic to case detection
efforts in resource-limited settings. The extent of delays,
substantially attributable to both the patients and health
system, could be as long as several weeks, months, or even
more than a year and varies in different geographical,
epidemiological and socio-political settings.9 In Ethiopia,
delays fluctuate across settings; from a median delay of 41
days in Northern11 to 45 days in Southern12 and 60 days in
North-western areas.13 A decade ago, median delay
exceeding two months and a maximum of 2 years delay
had also been reported in pastoralist settings.14 Failure to
timely detect and treat active TB cases affects patients,
community and the healthcare system. Extreme delays
exacerbate disease severity, advance dissemination, pro-
long patient suffering, increase fatality and adverse treat-
ment outcomes such as failure and drug resistance. It also
fuels disease transmission to close contacts.15,16 The
healthcare system will be burdened leading to extra health-
care costs to treat complicated disease forms.17
Therefore, assessing delays in TB care, and identifying
impediments in settings where passing case-finding is the
leading strategy is very important. Moreover, it is indis-
pensable in areas where TB is very prevalent but the case
detection rate is still very low. Thus, this study was aimed
to assess the extent of patient, health system and total
delays in diagnosis and treatment of pulmonary TB in
the Somali pastoralist setting, Eastern Ethiopia.
Patients and Methods
Study Setting
This study was conducted in the Somali regional state of
Ethiopia. In the region, more than 85% of the population
resides in rural areas, and lead either nomadic or agro-
pastoral way of life.18 Pastoralism is the main means of
subsistence of the community.19 Nomadic pastoralists rear
livestock and undergo seasonal transhumance movements,
and agro-pastoralists are engaged in mixed herding and
farming.14,20 In the setting, 10 hospitals and some selected
health centers provide TB diagnosis and treatment services
according to the national guideline.4 Diagnosis of Pulmonary
TB (PTB) includes smear microscopy, GeneXpert, chest
radiographs, pathological and clinical investigations.
Treatment is provided according to the national strategy,
Directly Observed Treatment-Short course (DOTS). This
study was conducted in four hospitals (Kharamara, Dege-
habour, Kebri-daher, and Gode) and in one health center
(Abilelie) found in the region. These facilities were selected
based on their high patient flow, presence of radiologic
facilities and wider geographical coverage.
Study Design and Population
A facility based cross-sectional study was conducted
between December 2017 and October 2018. Newly diag-
nosed PTB patients and aged ≥15 years were included irre-
spective of smear status and history of TB treatment. This
age category was chosen because patients ≥15 years of age
manifest similar pathological features, and the same diag-
nostic algorithm is followed.4 It is also the transition from
childhood to youth/adulthood at which people start seeking
care for their health demands.
Sample Size and Sampling Procedure
The minimum sample size calculated was 413 using
OpenEpi303 software for a single proportion in a population.
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Estimation parameters were 95% confidence interval, 80%
power, 42% of PTB patients delayed above 30 days in low-
and middle-income countries,9 5% precision and 10% non-
response rate. Adding up the available patients during the
study period yielded 444 patients as the final sample size.
All newly confirmed PTB patients and aged ≥15 years were
recruited prospectively starting from the initiation of the study.
Recruitment was done at DOTS clinics of the respective study
facilities as confirmed PTB patients arrived at the clinic to
initiate treatment while they had the sore illness before initia-
tion of therapy.
Data Collection
Data were collected using a pre-tested structured question-
naire administered by interviewers. Patient records were
also reviewed to gather information on clinical character-
istics and to crosscheck patient-reported clinical data. The
questionnaire was adapted from the World Health
Organization (WHO) study on diagnostic and treatment
delays in the Eastern Mediterranean region,21 and similar
studies in Ethiopia and abroad.14,22-24 It was translated into
local Somali and Amharic languages by two language
experts for each language, and inconsistencies were
resolved through mutual agreement. Nurses in the respec-
tive DOTS clinics conducted interviews and record
reviews after the provision of training on study objectives,
sampling procedures, interview techniques, questionnaire
contents, and ethical conformity. Interviewing patients
about the history of their illness might induce recall bias;
therefore, to alleviate this problem, we used the following
approaches. The first was interview time; patients were
recruited immediately as they arrived at the DOTS clinic
and before initiation of treatment. This was to minimize
recall bias that would happen if patients were asked after
illness recovery upon treatment initiation. The second was
the interview approach to measure time delays; the critical
first dates of symptom onset, medical consultation and
diagnosis were asked rather than asking the patients to
recall the number of days they delayed. Patients were
first asked to list the symptoms they had and the dates
each symptom started. Then they were asked the date of
first healthcare provider consultation, and the date they
were diagnosed as PTB patients. If patients were uncertain
of the critical dates, they were encouraged to associate
with notable religious or cultural events. Information was
also crosschecked by reviewing patient cards. The dura-
tions of delays (patient, health system, diagnosis, treatment
and total) were calculated using the characteristic dates of
symptom onset, provider consultation, diagnosis, and
treatment initiation.
Also, sputum smears were transported and examined
blindly by experienced laboratory technologists at
Armauer Hansen Research Institute laboratory in Addis
Ababa, Ethiopia. It was done to assess the quality of
microscopic examinations and the capacity of laboratory
technologists to detect acid-fast bacilli using Ziehl Neelsen
staining technique at peripheral health facilities.
Measurements
Patient delay: is defined as the time interval (days)
between the onset of a symptom(s) related to PTB and
the first date the patient consulted a healthcare provider at
a health center or hospital or private facilities with TB
diagnosis and treatment services. This excluded drug ven-
dors, health posts and traditional healers. Cough was used
as a benchmark of symptom onset, but other main symp-
toms that compelled the patient to seek healthcare were
considered in the absence of cough.
Health system delay: is defined as the time interval
(days) between the patient’s first consultation to
a healthcare provider and the date of diagnosis as PTB
patient. Health system delay was dichotomized at 14 days
cutoff (“non-delayed” if ≤14, and “delayed” if ≥15) con-
sidering two weeks delay as a programmatically tolerable
if TB cases had a smear-negative result at the initial
examination; otherwise, should be diagnosed in lesser
time.
Diagnosis delay: is defined as the time interval (days)
between the onset of pulmonary illness and the date of
diagnosis as PTB patient (sum of patient and health system
delays).
Treatment delay: is defined as the time interval (days)
from the date of diagnosis to treatment initiation.
Total delay: is defined as the total time interval (days)
between the onset of a symptom(s) related to PTB to date
of treatment initiation. (Figure 1)
Data Processing and Analysis
All data were double entered using EpiData 3.1 and ana-
lyzed using Stata version 14 (StataCorp, College Station,
Texas 77,845 USA). Data were summarized in frequencies
and median/mean depending on the type of variables.
Median and inter-quartile range (IQR) were used to sum-
marize patient, health system and total delays in diagnosis
and treatment of TB. As delays were skewed, non-
parametric Mann–Whitney and Kruskal–Wallis tests were
Dovepress Getnet et al
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used to compare patient and health system delays between
categories of explanatory variables. Mann–Whitney test
was used to compare delays between two categories of an
explanatory variable, and Kruskal–Wallis if a variable had
three or more groups. Box plots were used to illustrate
patient/total delays between pastoral and non-pastoral
patients, and health system delay between patients who
sought first care at health centers and hospitals. In addition,
we evaluated patient (clinical and socio-demographic) and
structural (health system-related) factors associated with
health system delay. The Log-binomial regression model
was employed to reveal factors associated with health sys-
tem delay ≥15 days. Statistical significance was determined
at P≤0.05, and P≤0.2 in the bivariate analysis was the cutoff
to include variables in the final multivariable model.
Estimates are presented in prevalence ratios with 95% con-
fidence intervals.
Results
Socio-Demographic Characteristics
In total, 444 newly diagnosed pulmonary TB patients were
recruited from four hospitals and one health center
between December 2017 and October 2018. The median
age of participants was 30 (IQR = 23–50) years, ranged 15
to 82 years. The majority (62.4%) of the patients were
male, illiterate (61.7%), and younger than 35 years con-
stituted 58.1%. Nearly half (46.4%) were pastoralists, of
which, 35.9% were nomadic. Concerning access to health
services, the median one-way walking time from patients’
dwelling to the nearest health facility was 40 minutes
(IQR=20–120 minutes), ranged 5 minutes to 720 minutes;
4 rural patients traveled 720 minutes (full day) to reach TB
care units (Table 1).
Clinical Characteristics
The majority of patients were new cases (90.1%), smear-
negative (57.9%), had an ambulatory physical condition
(77.0%), and 2.3% were TB/HIV co-infected. Of the main
TB-related symptoms, the commonly manifested symp-
toms in the course of the disease were cough (97.1%),
chest pain (63.7%), fatigue (43.5%), night sweating
(42.6%) and weight loss (35.4%). At the first presentation
to a healthcare provider, the majority of patients presented
with cough (91.0%) and chest pain (56.8%). TB-related
symptoms including hemoptysis, chest pain, fatigue, fever,
dyspnea, and smear positivity were higher in patients with
longer patient delay (Table 2).
Extents of Delays in Diagnosis and
Treatment of Pulmonary Tuberculosis
Patient Delay
The median patient delay from the onset of pulmonary illness
to the first provider visit was 30 days (IQR=19 – 48.5 days),
ranged from 2 days to 330 days. Of the total, only 14.2% and
30.4% sought medical attention within the recommended two
and three weeks of pulmonary illness (cough), respectively.
Median patient delays were higher in illiterate, rural, pastoral
and patients with long walking distance (Mann–Whitney/
Kruskal–Wallis tests, p<0.05) (Table 1). The median patient
delay of 35.5 days (IQR=23 – 66 days) among pastoralist
patients was higher than 27.5 days (17.5 – 43 days) among
urban/sub-urban patients [Mann–Whitney test, p<0.001]
(Figure 2). Of the total 444 patients, 11 pastoralists (2.5%)
Figure 1 Components of delays in diagnosis and treatment of pulmonary tuberculosis.
Getnet et al Dovepress
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had patient delay longer than six months (≥168 days). Patients
had taken various actions following the onset of illness; 76.5%
(338/442) visited healthcare facilities, 12.9% (57/442)
attempted traditional/self-remedy, 9.5% (42/442) visited
drug vendors and 1.1% (5/442) visited health extension work-
ers. The reasons to opt for the informal care were perceived
long waiting time/crowdedness at health facilities (32.7%),
lack of confidence in the quality of services (9.6%), fear of
service costs (5.8%), the remoteness of health facilities (25%),
bad experience in the past (24%), and others (2.9%). The
decision to visit healthcare provider was made by patients’
self-decision (52.7%), upon advice from family/close people
Table 1 Socio-Demographic Characteristics with Corresponding Patient and Health System Delays of PTB Patients in Somali Region,
Eastern Ethiopia, December 2017 to October 2018 (n=444)
Characteristics (n=444) Frequency (%) Patient Delay Health System Delay
Median P-value Median P-value
Sex
Male 277 (62.4) 30 (19–48) 0.70 15 (4–30) 0.15
Female 167 (37.6) 30 (19–49) 13 (5–26)
Age group
15 to 23 118 (26.6) 30 (19–45) 0.91 13 (4–23) 0.65
24 to 30 115 (25.9) 30 (18–46) 15 (5–30)
31 to 50 125 (28.2) 32 (20–50) 15 (5–30)
51+ 86 (19.4) 26.5 (20–53) 12.5 (4–30)
Literacy level
Illiterate 274 (61.7) 32 (21–56) 0.01 13 (5–29) 0.5
Primary 46 (10.4) 28.5 (15–43) 11 (4–25)
Secondary 66 (14.9) 28 (16–40) 18.5 (4–33)
Tertiary 58 (13.1) 29 (13–43) 14.5 (5–28)
Marital status
Single 133 (29.9) 30 (18–42) 0.33 14 (5–28) 0.03
Married 272 (61.3) 29 (19.5–53) 12.5 (4–28.5)
Divorced/widowed 39 (8.8) 32 (22–50) 22 (12–33)
Residence
Rural 219 (49.3) 35 (22–61) <0.001 13 (4–30) 0.29
Urban 221 (49.8) 27 (17–42) 15 (6–29)
Refugee/displaced 4 (0.9) ᶲᶲ ᶲᶲ
Livelihood
Pastoralism 206 (46.4) 35.5 (23–66) <0.001 13.5 (4–30) 0.48
Non-pastoralism 238 (53.6) 27.5 (17–43) 14 (5–29)
Income
Saving 57 (12.8) 30 (19–51) 0.09 20 (7–30) 0.11
Income=expense 309 (69.6) 32 (20–50) 14 (4–27)
Indebt 78 (17.6) 26 (16–41) 13 (5–33)
Access to nearest health facility (one-way)
An hour or less 307 (69.1) 27 (17–41) <0.001 12 (4–25) 0.01
One to two hours 60 (13.5) 36.5 (23–58) 17.5 (7.5–38)
More than two hours 77 (17.4) 56 (28–77) 17 (4–30)
A family member with a history of TB
Yes 90 (20.3) 30 (22–48) 0.36 13 (4–30) 0.68
No 341 (76.8) 30 (18–50) 14 (5–29)
Do not know 13 (2.9) ᶲᶲ ᶲᶲ
Note: ᶲᶲThe response category is dropped out of the analysis.
Dovepress Getnet et al
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(45.3%), and the rest (2.0%) were referred by health extension
workers, traditional healers and drug vendors.
Health System Delay
The median health system delay from the first healthcarepro-
vider consultation to diagnosis was 14 days (IQR = 4.5 – 29.5
days), ranged from 1 day to 98 days. Following healthcare
provider consultation, 48.4% of patients were not detected
as PTB patients within two weeks of consultation (the
programmatically tolerable delay if a patient was AFB smear-
negative at initial examination). Of all, 49.6% of patients had
an initial consultation at health centers, 45.7% at hospitals,
while 4.7% at private clinics with TB diagnosis services. The
median health system delays were 17.5, 8.0 and 28.0 days
among patients who made the first consultation in health
centers, hospitals, and private clinics, respectively (Kruskal–
Wallis test, p<0.001) (Figure 3). The median number of health
facility encounters was 2 (IQR=1 – 3); patients contacted 1 to
Table 2 Clinical Characteristics with Corresponding Patient and Health System Delays of PTB Patients in Somali Region, Eastern
Ethiopia, December 2017 to October 2018 (n=444)
Characteristics (n=444) Frequency (%) Patient Delay Health System Delay
Median P-value Median P-value
Functional status
Good 88 (19.8) 30.5 (19–43.5) 0.41 12.5 (5–21.5) 0.08
Ambulatory 342 (77.0) 30 (19–53) 15 (5–30)
Bedridden 14 (3.2) ᶲᶲ ᶲᶲ
Treatment category
New 400 (90.1) 30 (19.5–48.5) 0.53 14 (4.5–30) 0.79
Retreatment 44 (9.9) 32 (17–48) 14.5 (4.5–27)
History of TB
Yes 64 (14.4) 32 (18–50) 0.89 12.5 (5–29.5) 0.98
No 380 (85.6) 30 (19.5–48) 14 (4–29.5)
Smear status
Positive 187 (42.1) 37 (23–53) <0.001 10 (3–27) <0.001
Negative 257 (57.9) 26 (17–44) 16 (7–30)
Symptoms in the course of the disease
Cough 431 (97.1) 30 (19–50) 0.45 14 (4–30) 0.87
Hemoptysis 35 (7.9) 47 (25–70) 0.004 6 (2–23) 0.02
Chest pain 283 (63.7) 32 (20–51) 0.05 15 (4–29) 0.78
Dyspnea 97 (21.9) 33 (22–50) 0.23 13 (5–30) 0.81
Weight loss 157 (35.4) 29 (19–50) 0.84 9 (3–19) <0.001
Night Sweating 189 (42.6) 34 (20–54) 0.06 11 (4–26) 0.01
Fatigue 193 (43.5) 35 (21–56) 0.02 10 (3–23) <0.001
Fever 119 (26.8) 32 (19–63) 0.13 6 (2–25) <0.001
Appetite loss 102 (23.0) 34 (20–58) 0.18 6 (2–19) <0.001
Symptoms at first provider visit
Cough 404 (91.0) 30 (18–49.5) 0.68 13 (4–28.5) 0.01
Hemoptysis 32 (7.2) 47 (25–70) 0.004 6 (2–23) 0.02
Chest pain 252 (56.8) 32 (20–51.5) 0.1 14 (4–27) 0.10
Dyspnea 61 (13.7) 35 (23–58) 0.05 9 (2–29) 0.21
Fatigue 189 (42.8) 32 (20–51) 0.27 11 (4–25) 0.01
Fever 129 (29.0) 35 (23–52) 0.01 9 (2–30) 0.04
HIV status
Positive 10 (2.3) 37 (21–46) 0.9 28.5 (14–46) 0.06
Negative 432 (97.3) 30 (19–50) 14 (4–29)
Unknown 2 (0.4) ᶲᶲ ᶲᶲ
Note: ᶲᶲThe response category is dropped out of the analysis.
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6 health facilities before being confirmed as PTB patient. The
median health system delay was higher in smear-negative (16
days) than smear-positive (10 days) (Mann–Whitney test,
p<0.001); whereas patients presented with cough, hemoptysis,
fatigue, and fever had shorter median health system delays
(Mann–Whitney test, p<0.05) (Table 2).
Total Delays to TB Diagnosis and Treatment
The median diagnosis delay from onset of pulmonary illness
to diagnosis (sum of patient and health system) was 49 days
(IQR = 33.5 – 71.5 days), ranging from 8 days to 362 days,
and the median treatment delay from diagnosis to treatment
initiation was 1 day (IQR = 1 – 2 days), ranged from 1 day to
18 days. The median total delay from the onset of pulmonary
illness to treatment initiation was 50 days (IQR = 35 – 73.5
days), ranged from 9 days to 363 days. Of all, 82.4% of
patients experienced a delay longer than a month and 3.8% of
patients (16 pastoralists and 2 non-pastoralists) longer than
six months prior to treatment initiation. The median total
delay of 58.5 days (IQR=38 – 90 days) among pastoralist
patients was significantly higher compared to 46.5 days
(IQR=33 – 63 days) among urban patients [Mann–Whitney
test, p<0.001]. (Figure 4)
Factors Associated with Health System Delay
After adjusting for potential confounders, the health system
delay ≥15days was associated with clinical and health system
related factors. Of the patient factors, health system delay
≥15days was associatedwith the manifestation of only two or
fewer symptoms [APR (95% CI) = 1.4 (1.1 – 1.7)], smear-
negative results at diagnosis [APR (95% CI) = 1.2 (1.01 –
1.5)], and multiple (≥2) provider visits [APR (95% CI) = 5.8
(3.5 – 9.6)] compared to patients with multiple symptoms,
smear-positive result, and diagnosed at the first visit, respec-
tively. Of the structural factors, health system delay ≥15 days
was higher in patients who made the first visit to health
centers [APR (95% CI) = 1.6 (1.3 – 2.0)] compared to
patients who sought first care at hospitals. Upon rechecking
of sputum smears at the referral laboratory, 19.2% of smear-
positive and 2.9% of smear-negative results were misdiag-
nosed in health centers or hospitals. (Table 3)
Discussion
In this study, the median patient, health system, treatment,
and total delays were 30, 14, 1 and 50 days, respectively.
Figure 2 Patient delay among pastoralist and non-pastoralist PTB patients in Somali
Region of Ethiopia, December 2017 to October 2018.
Figure 3 Health system delay among PTB patients who sought the first consulta-
tion in health centers and hospitals in Somali Region of Ethiopia, December 2017 to
October 2018.
Figure 4 Total delay among pastoralist and non-pastoralist PTB patients in Somali
Region of Ethiopia, December 2017 to October 2018.
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Table 3 Factors Associated with Health System Delay ≥15 Days Among PTB Patients in Somali Region, Eastern Ethiopia,
December 2017 to October 2018, Log-Binomial Regression Model (n=444)
Characteristics (n=444) Total PTB Cases
n (%)
HSD ≥15 Days
n (%)
P-value PR (95% CI) P-value APR (95% CI)
Sex Female 167 (37.6) 87 (52.1) 0.23 1.1 (0.9, 1.4) 0.12 1.2 (0.9, 1.4)
Male 277 (62.4) 128 (46.2) 1 1
Literacy level Illiterate 274 (61.7) 129 (47.1) 0.68 0.9 (0.7, 1.3) — —
Formal 112 (25.2) 57 (50.9) 0.91 1.0 (0.7, 1.4) — —
Tertiary 58 (13.1) 29 (50.0) 1
Residence Urban 221 (49.8) 111 (50.2) 0.44 1
Rural 219 (49.3) 102 (46.6) 0.9 (0.8 1.1) — —
Displaced/
refugee
4 (0.9)ᶲᶲ 2ᶲᶲ – –
Livelihood Pastoralism 206 (46.4) 97 (47.1) 0.6 0.9 (0.8, 1.1) — —
Non-pastoralism 238 (53.6) 118 (49.6) 1
Income Savings 57 (12.8) 32 (56.1) 1 1
Income=expense 309 (69.6) 147 (47.6) 0.21 0.8 (0.7, 1.1) 0.19 0.8 (0.6, 1.1)
Indebt 78 (17.6) 36 (46.2) 0.25 0.8 (0.6, 1.1) 0.40 0.9 (0.6, 1.2)
Smoking history Never smoker 399 (89.9) 196 (49.1) 0.4 1
Ever smoker 45 (10.1) 19 (42.2) 0.9 (0.6, 1.2) — —
Type of first consultation facility Health center 220 (49.6) 130 (59.1) <0.001 1.7 (1.3, 2.1) <0.001 1.6 (1.3, 2.0)
Hospital 203 (45.7) 72 (35.5) 1 1
Private clinicᶲᶲ 21 (4.7) ᶲᶲ 13 (61.9) ᶲᶲ – –
No. of healthcare providers
consulted
Single encounter 137 (30.9) 15 (11.0) <0.001 1 <0.001 1
≥2 encounters 307 (69.1) 200 (65.1) 5.9 (3.7, 9.6) 5.8 (3.5,9.6)
Smear status Negative 257 (57.9) 140 (54.5) 0.003 1.4 (1.1, 1.7) 0.05 1.2 (1.01, 1.5)
Positive 187 (42.1) 75 (40.1) 1 1
TB category New 400 (90.1) 193 (48.3) 0.82 0.96 (0.7, 1.3) — —
Retreatment 44 (9.9) 22 (50.0) 1
Cough at first HCP consultation Yes 404 (91.0) 190 (47.0) 0.03 0.75 (0.57, 0.97) 0.4 0.9 (0.7, 1.2)
No 40 (9.0) 25 (62.5) 1 1
Hemoptysis at 1st HCP
consultation
Yes 32 (7.2) 10 (31.3) 0.08 0.6 (0.4, 1.1) 0.6 0.9 (0.5, 1.5)
No 412 (92.8) 205 (49.8) 1 1
Chest pain at first HCP
consultation
Yes 252 (56.8) 121 (48.4) 0.84 0.98 (0.8, 1.18) — —
No 192 (43.2) 94 (48.9) 1
TB related symptoms at first
HCP visit
Two or less 196 (44.1) 113 (57.7) 0.001 1.4 (1.2, 1.7) 0.001 1.4 (1.1, 1.7)
Three or more 248 (55.9) 102 (41.1) 1 1
(Continued)
Getnet et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Risk Management and Healthcare Policy 2020:13590
 
R
is
k 
M
an
ag
em
en
t a
nd
 H
ea
lth
ca
re
 P
ol
icy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
15
2.
36
.2
42
 o
n 
26
-J
un
-2
02
0
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Pastoralist patients experienced longer patient delays
(median=35.5 days) compared to non-pastoralist comple-
ments (median=27.5 days), and it was also higher in illit-
erate and patients who traveled longer to reach health
facilities. First visit to health center was structural-
related; smear negativity, the manifestation of few symp-
toms, and multiple provider visits (could be structural)
were patient-related factors associated with health system
delay ≥15 days.
In this study, 85.8% and half of PTB patients delayed
longer than two weeks and a month without seeking med-
ical attention, respectively. It was very excessive as the
national TB control expectation is every person with
a cough to visit the nearest healthcare facility within two
weeks from the onset of the cough.4 It was also longer
than reports in some areas of Ethiopia such as Dessie,25
West Gojjam,13 South-western,26 and Addis Ababa.27
Nonetheless, the median delay was comparable with
reports in South,12 north,28 north-west,29 and central30
parts of the country. The disparities might be due to con-
trasts in demographics, socioeconomics, access to health
services, and cognitive aspects.31,32 Moreover, patient
delay was notably longer among pastoralists than counter-
parts in the study and elsewhere.13,28 The underlying cause
could be due to the limited access to healthcare in the
pastoralist setups of the country, and the nature of lifestyle
that forces them to move from place to place making
access to healthcare difficult.33 Patients walk long hours
to reach the nearby health facilities in the pastoralist setups
as infrastructure is not well developed, almost all of the
health posts (lowest level in the healthcare tier) and the
majority of health centers in the region did not provide TB
services.8 During the fieldwork, the intricacy was observed
to be worse in dry seasons between January and April due
to the movement of pastoralists to remote grasslands.
Additional to limited access, informal providers could
also contribute to longer patient delay, a quarter of patients
sought informal care due to reasons such as crowdedness,
lack of confidence, fear of service costs, remoteness, and
bad experience in health facilities.
Half of the patients were not detected within two
weeks of consultation with healthcare providers. It reveals
a high degree of missed opportunities to ensure early
diagnosis due to healthcare system deficiencies. The med-
ian delay of 14 days by the healthcare system was worse
than reports in other parts of the country like Addis,27
Dessie,25 and Gondar11 but comparable with reports in
West-Gojjam13 and south-western Ethiopia.26 In general,
the combined effect of patient and health system delays
inflated the median total delay in treatment to 50 days, and
it reached close to a year for some patients. Cognizant of
30 days delay as the critical point of disease devastation
and transmission,34,35 the highest segment of patients
(82.4%) with delay above 30 days reveals a prospect of
abundant undetected and infectious cases in communities.
This implies the risks of TB transmission, dissemination,
death, treatment failure and drug resistance could be high
in the setting as a result of excessive delays.15
Total delays were attributable to factors influencing
patients’ healthcare-seeking behavior and the healthcare
system’s efficiency to examine TB cases. The determinants
of patient delay are available in a related study;31 whereas,
health system delay ≥15 days was associated with clinical
features and first visit to health centers. Patients with mild
symptoms at first presentation experienced health system
delay compared to those who presented with hemoptysis,
chest pain, fever, and dyspnea. This might be because
providers fail to suspect TB among patients with mild
illness at first visit; most of the time would misclassify it
to other respiratory illnesses than TB. As reported
elsewhere,13,25 health system delay ≥15 days was also
associated with smear negativity. Patients with smear-
negative results at the initial examination are administered
with antibiotics and rechecked after two weeks.4 However,
Table 3 (Continued).
Characteristics (n=444) Total PTB Cases
n (%)
HSD ≥15 Days
n (%)
P-value PR (95% CI) P-value APR (95% CI)
Functional status at 1st HCP
consultation
Good 65 (14.6) 27 (41.5) 0.18 0.8 (0.6, 1.1) 0.06 1.3 (0.9, 1.8)
Ambulatory 365 (82.2) 187 (51.2) 1 1
Bedridden ᶲᶲ 14 (3.2) ᶲᶲ 1ᶲᶲ — — — —
Notes: ᶲᶲThe response category is dropped out of analysis. —Not included in the final model.
Abbreviations: HCP, healthcare provider; HSD, health system delay; PR, prevalence ratio; APR, adjusted prevalence ratio; 1, reference category.
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the patients might not come on a scheduled date or opted
for other facilities if negative again upon rechecking or not
recovering, which causes further delay.
First visit to health centers also increased health system
delay. The basis could be due to unavailability and poor
quality of diagnostic services. Although they were the first
points of care for half of the patients, two-third of health
centers in the region did not provide laboratory services,8
and none of them possess tools to examine smear-negative
cases such as X-ray or GeneXpert. Furthermore, the majority
of the health centers are staffed with low- or middle-level
junior professionals so that they might have skill limitations to
suspect and diagnose TB cases.36 In this study, providers at
frontline facilities incorrectly diagnosed 19.2% of smear-
positive as smear-negative patients. Thus, the health system
delays could have resulted from poor competency of provi-
ders and low capacity of health facilities to diagnose TB cases.
However, the extent of delay might be underestimated as
a result of recall and misrepresentation biases. Patients are
likely to recall the date when the illness gets severe but not
the exact date of onset, and if pastoralists were represented
proportionally, the patient delay could have increased.
Conclusion
This study highlights that timely detection and treatment of
pulmonary tuberculosis remains a serious challenge in the
Somali pastoral setting of Ethiopia. Over half of pulmonary
TB patients delayed longer than seven weeks without
obtaining treatment, which is attributable to patient and
health system delays with a certain inclination to patient
delay. The extended delays reveal the magnitude of unde-
tected TB cases could be great in communities, and thus the
leading cause of low case detection rates in the region for
years in a row. Delays were associated with clinical, socio-
demographic, service accessibility and availability factors
that affect the healthcare-seeking of patients, skill of health-
care providers and capacity of healthcare facilities. Hence,
expansion of TB services better tailored to pastoralists
including mobile services and community engagement can
be helpful to reduce patient delays; whereas, availing diag-
nostic services at health centers, delivering better equipment,
and enhancing the competency of frontier providers can be
effective strategies to tackle health system delays.
Abbreviations
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Institute; APR, adjusted prevalence ratio; CI, confidence
interval; DOTS, Directly Observed Therapy-Short Course;
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